Wegovy Pill vs Foundayo (Orforglipron): Cost and Results

Two weight-loss pills now sit on the same shelf, and your doctor may ask which one you prefer. That is a new problem. Until recently, the main choice was a weekly shot.

So how does the Wegovy pill vs Foundayo choice work? Both are FDA-approved and taken by mouth. Cash prices for each start at $149 a month. Still, they differ in results, in price at higher doses and in daily routine.

The timing matters. A KFF poll fielded in late 2025 found that about 1 in 8 US adults say they take a GLP-1 drug. Many users also said the cost was hard to afford. Cheaper pills could change who gets treatment. This guide compares the two side by side. It is for information only, and your doctor decides what fits you.

Quick answer: The Wegovy pill (semaglutide) and Foundayo (orforglipron) are both FDA-approved daily pills for adults with obesity, or with overweight plus a weight-related health problem. Cash prices start at $149 a month and rise with the dose. The trials were separate, not head-to-head, so the results are not a direct match.

Wegovy pill vs Foundayo: how do the two pills compare?

Both pills are once-daily tablets for adults with obesity, or with overweight plus a weight-related health problem. They differ most in the drug itself, the trial results and the price at higher doses.

Prices last checked Nov 8, 2026. Sources: FDA and Lilly prescribing information, Novo Nordisk, Lilly, CMS.

The two trials do not match. They ran for different lengths, in different groups, with different drugs. So the numbers cannot be ranked like a race result.

For example, a 64-week result and a 72-week result use different yardsticks. A gap of a few points may reflect how each trial was run. As a result, price and daily routine often matter more than one number.

Takeaway: Two pills, two separate trials, and no head-to-head winner.

What are oral GLP-1 pills and how do they work?

Oral GLP-1 pills are daily tablets that copy a hormone your gut makes after meals. That hormone is GLP-1, short for glucagon-like peptide-1. It tells the brain you are full and slows how fast the stomach empties.

Drugs that copy it are called GLP-1 receptor agonists. A receptor is a docking spot on a cell. The drug works like a key that fits it.

The Wegovy pill uses semaglutide. CBS News reported that this is the same ingredient as in the Wegovy and Ozempic injections. Foundayo uses orforglipron, which is a small-molecule drug rather than a peptide.

Why does that matter? Novo Nordisk has said pills cost less to make and need no refrigeration, as ABC News reported. So a tablet can travel in a pocket without a cold pack.

Wegovy pill: approval, results and cost

The FDA approved the Wegovy pill on December 22, 2025, as the first daily oral GLP-1 for weight loss. Its full dose is 25 mg of semaglutide, according to the FDA prescribing information.

In the 64-week OASIS 4 trial, the FDA label shows people on the 25 mg pill lost 13.6% of body weight on average, compared with 2.4% on placebo. The trial was published in the New England Journal of Medicine. Applied Clinical Trials reported that people who took the pill as directed lost 16.6%, versus 2.7% on placebo.

Novo Nordisk sells four strengths: 1.5 mg, 4 mg, 9 mg and 25 mg. CNN reported that doses start low and rise slowly to limit side effects. Cash prices run from $149 to $299 a month, depending on the dose. With commercial coverage, some people pay as little as $25, according to Drugs.com.

The $149 starting price came from a deal with the Trump administration announced in November 2025, CNN reported. Our post on TrumpRx and drug costs explains what that program does and does not change.

So the first month is cheap, but the long-term dose costs more.

Foundayo (orforglipron): approval, results and cost

The FDA approved Foundayo on April 1, 2026, and Lilly made it available on April 9. According to Lilly’s announcement, it is sold through LillyDirect, telehealth providers and retail pharmacies.

In the 72-week trial described in Lilly’s prescribing information, people on the 17.2 mg dose lost 11.1% of body weight on average, compared with 2.1% on placebo. Lower doses lost less: 7.4% at 5.5 mg and 8.3% at 9 mg. Lilly says the study was published in the New England Journal of Medicine, and Weill Cornell Medicine summarized it.

Self-pay starts at $149 a month at the lowest dose. Lilly’s LillyDirect page lists $149 for 0.8 mg and 2.5 mg, $199 for 5.5 mg and $299 for 9 mg. The 14.5 mg and 17.2 mg doses are $299 if you refill within 45 days, and regular prices apply after that. Diatribe reported that those regular prices reach $349. Prices for 2.5 mg and 5.5 mg are temporarily reduced through December 31, 2026.

Lilly says Foundayo can be taken at any time of day without food or water limits, and its label says to take it with or without food. The Wegovy pill label says to take that pill on an empty stomach with up to 4 ounces of water and wait 30 minutes before eating or drinking. Ask your doctor which routine would suit your day.

Foundayo is approved for weight management in adults. Lilly has said it plans to seek approval for type 2 diabetes.

GLP-1 pill vs injection: which is better?

Neither is better for everyone. The right choice depends on cost, routine, the dose you need and your doctor’s advice.

Pills – No needles, and no fridge, per Novo Nordisk. – Cash prices run $149 to $349 a month. – Taken daily, so missed doses are easier.

Injections – Taken weekly. – Cash prices run about $199 to $399 a month, NPR reported. – A higher-dose Wegovy injection (7.2 mg) was approved on March 19, 2026, per Drugs.com.

GoodRx notes that the 25 mg Wegovy pill may lead to weight loss similar to the 2.4 mg injection. It also says both forms share similar side effects because the ingredient is the same. Still, no trial here compares Foundayo with an injection directly.

What most people are missing about GLP-1 pill prices

The starting price hides the real cost. Both pills use a dose ladder. You begin low and climb. Cash prices climb too.

For cash payers, the cheaper pill depends on the dose you land on. Wegovy pill tops out at $299 and Foundayo at $299 to $349, depending on refill timing. Neither number tells you which pill works better for you.

Medicare changes the math. Eligible adults pay $50 for either pill, so cost drops out. Then routine, side effects and your doctor’s view decide.

Takeaway: Compare the price at your dose, not the headline price.

Who qualifies for GLP-1 weight loss pills, and who should be careful?

Adults with obesity, or with overweight plus a weight-related health problem, may qualify. Both labels cover adults using the pill with a reduced-calorie diet and more physical activity. The labels’ indications don’t list numeric BMI cutoffs. Foundayo’s main trial enrolled adults with a BMI of 30 or more, or 27 to under 30 with a related condition, according to its prescribing information.

Who should be careful. Both labels carry a boxed warning about thyroid C-cell tumors. Neither pill should be used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Read the full warnings section of each label for other risks.

Myths vs facts – Myth: A pill replaces diet and exercise. Fact: Both are approved alongside them. – Myth: One pill is simply stronger. Fact: The trials were separate, so no one can say.

See a qualified professional before starting, stopping or changing any dose. This guide gives no dosing advice.

Does Foundayo have insurance coverage? Medicare and cash prices

Often yes, if your plan covers it. Lilly says commercially insured people may pay as little as $25 a month with a savings card. Coverage varies by plan, so check yours.

Medicare. Medicare. The Medicare GLP-1 Bridge is a short-term demonstration that runs from July 1, 2026 to December 31, 2027. CMS says eligible Part D beneficiaries pay a $50 copay. Medicare.gov says you are not eligible if a GLP-1 drug is already covered by your Medicare drug plan. AARP reported that about 3.8 million people could qualify.

Cash. Prices above are last checked Nov 8, 2026.

Why this matters right now. Cost is a leading barrier. A KFF poll fielded Oct 27 to Nov 2, 2025 found 12% of adults currently take a GLP-1 drug. About 56% of users said the drugs were hard to afford. Also, 14% of users had stopped because of cost.

GLP-1 pill side effects and what to ask your doctor

Stomach problems are the most common side effects. These include nausea, vomiting, diarrhea and constipation, In Foundayo’s label, at 17.2 mg, nausea affected 35% of people vs 10% on placebo, vomiting 24% vs 4%, diarrhea 25% vs 11% and constipation 24% vs 9%. For the Wegovy pill’s rates, see the side-effects section of its prescribing information.

Because Wegovy pill and injections share semaglutide, their side effects are similar, GoodRx notes. Foundayo’s trial reports also describe stomach side effects as common.

Eating patterns affect how your gut feels. For background, see our posts on processed foods and the gut-brain connection.

Questions to bring to your doctor – Do I qualify, and which pill fits my health history? – What will I pay at each dose, with and without coverage? – Do my other medicines interact with it? – Which side effects should make me call you? – How long will I stay on it, and what happens if I stop?

Around the world: generic semaglutide abroad and the US wait

Generic semaglutide is already sold in India, and other countries have opened to generics, but the US waits. Patents have ended or lapsed in Canada (January 2026), India (March 2026), Brazil, China, South Africa and Turkey, per Abel & Imray. Pharmacy.biz reported more than 50 Indian brands were expected.

Abel & Imray says US protection is expected to last until at least 2032. Europe’s runs to March 2031. Foundayo is a different molecule, so these patent dates do not apply to it.

The bigger picture. India supplies about 20% of the world’s off-patent medicines, per the same source. Cheaper semaglutide there may push prices down elsewhere.

What could happen next. The Bridge ends December 31, 2027. Lilly may add a diabetes approval. US generics are years away. Which of these shifts cash prices first is uncertain.

Conclusion

The Wegovy pill vs Foundayo choice has no proven winner. The trials were separate. Price at your dose, daily routine, coverage and your doctor’s view matter more. Watch two things: price changes and the Medicare Bridge end date. Next, write down your questions and take them to a qualified professional.

Frequently Asked Questions